Back to Search
Start Over
RedHill Biopharma plans to initiate Phase 3 study of RHB-204 in Q3
- Source :
- The Fly. May 27, 2020
- Publication Year :
- 2020
-
Abstract
- Following recent data from an ongoing supportive non-clinical program, RedHill plans to initiate a single, pivotal Phase 3 study evaluating RHB-204 as a first-line, stand-alone treatment for pulmonary NTM infections [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- The Fly
- Publication Type :
- Periodical
- Accession number :
- edsgcl.624992919